“SWIFT-seq is a powerful option as it can measure the number of CTCs, characterize the genomic alterations of the tumor, ...

Multiple myeloma is a chronic blood cancer affecting plasma cells, but with today’s treatments many patients can manage symptoms and live fulfilling lives.

Despite growing recognition of the importance of the peripheral immune system in neurodegenerative disease, little is known about how these blood cells change in Alzheimer’s and Parkinson’s diseases.

Background and aims Liver failure syndromes are characterized by a dysregulated immune response leading to immune paralysis.

Cutting off blood flow ages the bone marrow, weakening the immune system’s ability to fight cancer, a new study finds.

Background Acute-on-chronic liver failure (ACLF) is a life-threatening syndrome involving dysfunction of multiple immune cell ...

The CAR T cell therapy, called NXC-201, targets a protein called BCMA, which is expressed on the surface of amyloid plasma cells and drives cancer growth. In the first 10 patients to receive the ...

The trial aims to enroll up to 24 patients with relapsed or refractory multiple myeloma, a blood cancer that arises in plasma cells in the bone marrow.